Abstract
A significant portion of pediatric epilepsy is intractable, resulting in a burden substantial enough to lead a family to choose surgical intervention. In recent years, advancements in clinical practice, technology, and pre-surgical evaluation procedures have improved post-surgical outcomes. In this short review, we highlight some of the pivotal advances in pediatric epilepsy surgery that have contributed to and continue to contribute to increased success rates.
Current Pediatric Reviews
Title: Advances in Pediatric Epilepsy Surgery
Volume: 8 Issue: 1
Author(s): Jennifer L. Robinson, Vasilios Zerris and Gerhard Friehs
Affiliation:
Keywords: DBS, DTI, fMRI, imaging, MRI, TMS
Abstract: A significant portion of pediatric epilepsy is intractable, resulting in a burden substantial enough to lead a family to choose surgical intervention. In recent years, advancements in clinical practice, technology, and pre-surgical evaluation procedures have improved post-surgical outcomes. In this short review, we highlight some of the pivotal advances in pediatric epilepsy surgery that have contributed to and continue to contribute to increased success rates.
Export Options
About this article
Cite this article as:
L. Robinson Jennifer, Zerris Vasilios and Friehs Gerhard, Advances in Pediatric Epilepsy Surgery, Current Pediatric Reviews 2012; 8 (1) . https://dx.doi.org/10.2174/157339612799746326
DOI https://dx.doi.org/10.2174/157339612799746326 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial: In Silico Studies in Drug Research Against Neurodegenerative Diseases
Current Neuropharmacology Recent Developments in Anxiety Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases
Current Drug Targets Importance of P-gp PET Imaging in Pharmacology
Current Pharmaceutical Design The Prophylactic Use of Antiepileptic Drugs in Patients Scheduled for Neurosurgery
Current Pharmaceutical Design A Review of the Pharmacological Properties of 3,4-dihydro-2(1H)- quinolinones
Mini-Reviews in Medicinal Chemistry Somatostatin sst4 Ligands: Chemistry and Pharmacology
Mini-Reviews in Medicinal Chemistry Subtype-Selective Noncompetitive Modulators of Metabotropic Glutamate Receptor Subtype 1 (mGluR1)
Current Topics in Medicinal Chemistry Nutritional and Pharmacological Management of Childhood Epilepsy: Ketogenic Diets and Common AEDs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Determination of Phytochemicals by GC-MS in Two Fractions (17 and 21) of Methanol Extract of Loranthus Micranthus and their Antioxidant and Anti-Inflammatory Activity
The Natural Products Journal Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance
Current Topics in Medicinal Chemistry Gut Microbiota Regulate Astrocytic Functions in the Brain: Possible Therapeutic Consequences
Current Neuropharmacology Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology Inquiries into the Biological Significance of Transmembrane AMPA Receptor Regulatory Protein (TARP) γ−8 Through Investigations of TARP γ−8 Null Mice§
CNS & Neurological Disorders - Drug Targets Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
Current Medicinal Chemistry Neurogenic Drugs and Compounds to Treat CNS Diseases and Disorders
Central Nervous System Agents in Medicinal Chemistry Purines and Pyrimidines: Metabolism, Function and Potential as Therapeutic Options in Neurodegenerative Diseases
Current Protein & Peptide Science Assessing Structure, Function and Druggability of Major Inhibitory Neurotransmitter γ-Aminobutyrate Symporter Subtypes
Current Medicinal Chemistry AMPA Receptor Antagonists for the Treatment of Stroke
Current Drug Targets - CNS & Neurological Disorders